TGA warns about capsule interactions

Regulator says Grakcu can have dangerous interactions with other prescription medicines The Therapeutic Goods Administration (TGA) says Grakcu capsules can pose a “serious risk to health” and shouldn’t be taken by patients. Laboratory testing by the TGA found the capsules contained undeclared medicines sildenafil and tadalafil, which are used in the treatment of erectile dysfunction (ED).